Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “CHINA PHARMACEUTICAL UNIVERSITY”

30 pharma patents match "CHINA PHARMACEUTICAL UNIVERSITY" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 30
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 30 pharmaceutical patents matching "CHINA PHARMACEUTICAL UNIVERSITY" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

30 results for “CHINA PHARMACEUTICAL UNIVERSITY” · 30,257 patents in full index Clear search

  1. US 12383535

    Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method therefor

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  2. US 12331058

    SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the same

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  3. US 12310944

    Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted May 27, 2025 · Expires May 22, 2045

    granted
  4. US 12226476

    Helper epitope peptide and application thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  5. US 12144881

    Cosmetic composition containing α-mangostin, method for preparation, and uses thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  6. US 11993603

    Preparation for 6-amino-1H-pyrazolo[3,4-d]pyrimidine-based JAK kinase inhibitor and application thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted May 28, 2024 · Expires May 23, 2044

    granted
  7. US 11970523

    Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  8. US 11773057

    Naphthalenesulfonamide compound, preparation method, and application

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  9. US 11572359

    PARP/PI3K double-target inhibit containing pyridopyrimidine structure

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  10. US 11541032

    Composition containing sumo inhibitor and application

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  11. US 11504385

    Proteolysis targeting chimeric molecule, preparation method, and application

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  12. US 11479545

    Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interaction

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted
  13. US 11304926

    Application of transient receptor potential cation channel TRPV3 in developing drug for preventing or treating psoriasis

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  14. US 11085022

    Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted
  15. US 11078250

    High-activity long-acting hypoglycemic fusion protein as well as preparation method and medical application thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  16. US 11021454

    Type of aryl benzofuran amidated derivative and medical use thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  17. US 11014895

    Heterocyclic urea compound, and drug composition and application thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted May 25, 2021 · Expires May 20, 2041

    granted
  18. US 10875903

    Bifunctional fusion proteins to inhibit angiogenesis in tumor microenvironment and to activate adaptive immune responses and the genes and uses thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  19. US 10639289

    Application of neuraminidase and inhibitors thereof in myocardial ischemia and myocardial infarction

    CHINA PHARMACEUTICAL UNIVERSITY · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  20. US 10526370

    Pentapeptide associated with integrin receptor alpha vbeta3

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted
  21. US 10442759

    1-sulfonamido-4-aryloxy compounds, and preparation method and medicinal application thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted
  22. US 9943524

    Use of alkaloid in preparing pharmaceutical compositions for preventing or treating pulmonary fibrosis

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted
  23. US 9822089

    R type of resveratrol dimer, preparation process therefor and purpose thereof in lowering blood sugar level

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  24. US 8859527

    Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treatment of cancer thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted